Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Product/Service

DXC Technology Supports Zurich's Infrastructure Transformation with Five-Year Extended Contract


DXC Technology (NYSE: DXC) announced today that Zurich Insurance Group (Zurich) has extended its agreement with DXC to provide IT and security services over the next five years as a vital component of the company's IT transformation. This applications-led infrastructure and application modernization will help Zurich improve its overall customer and employee experience.

As part of the enhanced agreement, Zurich will leverage DXC capabilities across the Enterprise Technology Stack. This will provide Zurich with the ability to deploy applications faster through automation, helping them to introduce new products quickly and at scale, and to improve operational resiliency.

"We put our customers' needs at the center of everything we do. Enhancing and automating our core insurance processes will help us to provide customers with a better experience, whether they purchase a new insurance policy or are filing a claim," said Daniel Englberger, Chief Operating Officer, Group Technology & Operations, Zurich Insurance Group. "DXC's IT and security services, as well as the joint applications-led infrastructure modernization initiative, will contribute to the overall framework powering our digitization strategy."

"Zurich is a valued DXC customer and we welcome the opportunity to be part of the company's global transformational journey," said Mike Salvino, President and CEO, DXC Technology. "We listened carefully to Zurich's needs and are excited to deliver our capabilities across the Enterprise Technology Stack to benefit the company, its people and customers."

About DXC Technology

DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world's largest companies trust DXC to deploy the Enterprise Technology Stack to deliver new levels of performance, competitiveness and customer experiences. Learn more about the DXC story and our focus on people, customers and operational execution at www.dxc.technology.

About Zurich Insurance Group

Zurich is a leading multi-line insurer that serves its customers in global and local markets. With about 55,000 employees, it provides a wide range of property and casualty, life insurance products and services in more than 215 countries and territories. Zurich's customers include individuals, small businesses, and mid-sized and large companies, as well as multinational corporations. For more information visit: www.zurich.com


These press releases may also interest you

at 03:30
Amflow, the eMTB expert that builds e-bikes from heart to body, today marks its entry into the industry with the launch of the Amflow PL. Providing a significantly robust 850 W of peak power and weighing in at an industry leading level of ultra-light...

at 03:17
Daniels Manufacturing Corporation® (DMC®) is proud to announce the successful acquisition of MCD-Tools GmbH, a leading tool distribution and repair company based near Frankfurt, Germany. DMC's acquisition of MCD-Tools allows DMC to form DMC Europe...

at 03:05
NielsenIQ (NIQ) today announced the availability of NIQ Activate in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. NIQ customers can now take advantage of the productive and trusted Azure cloud...

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
Manhattan Associates today announced that it has been named winner of the VIP Awards' Best Sustainability Initiative category for 2024. Selected from a competitive group of nominees, Manhattan Active® Supply Chain technology was chosen because of...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...



News published on and distributed by: